Clinical insights, treatment breakdowns, and evidence-based guidance from Amber Tomse, FNP-C — written for patients who want real answers, not marketing fluff.
As longevity and regenerative medicine continue to evolve, a growing number of therapies are being explored to support healthy aging. Amber breaks down the latest science behind each approach.
Read Article
Exosome therapy is becoming a cornerstone of regenerative and aesthetic medicine. Which type is right for you?
Retatrutide is one of the most anticipated metabolic therapies in development. Here's what the data actually says.
The conversation around women's hormone health has finally taken a long-overdue turn. Here's what changed and what it means for your care.
GLP-1 medications revolutionized metabolic medicine — but they can slow digestion and disrupt the gut microbiome. Here's how to stay ahead of it.
Tired of being told it's "just menopause"? Peptide therapy is offering women a new path through the transition — backed by science.
From BPC-157 to Epithalon — a clinical breakdown of the five peptides Amber recommends most often for patients focused on aging well.
When it comes to peptide serums, not all formulas are created equal. Here's how these two stack up under clinical scrutiny.
If you're ready to feel more energized, think clearer, and support your body's natural repair systems — this protocol is worth understanding.
The human gut is home to trillions of microorganisms. Dysbiosis disrupts everything — and BPC-157 with KPV may offer a targeted path back to balance.
Showing 9 of 75+ articles — browse all →
New posts on GLP-1s, hormones, peptides, and aesthetics — delivered when it matters. No spam. Just the kind of information your doctor probably isn't sharing.
No spam. Unsubscribe anytime. HIPAA-compliant platform.
